切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - GABAA Receptors - M2 Receptors - Urokinases - ALK

15件产品中的 1-10

页面
每页
清除全部
  1. Entrectinib
    B5859 Entrectinib
    中文名: 恩曲替尼
    Target: Trk Receptors|ALK|ROS1
    Summary: ALK激酶抑制剂
      ≥28.05 mg/mL
      insoluble in H2O
  2. PF-06463922
    B4882 PF-06463922
    中文名: 劳拉替尼
    Target: ALK|ROS1
    Summary: ALK/ROS1的强效选择性抑制剂
      ≥20.3 mg/mL
      insoluble in H2O
  3. Amiloride HCl dihydrate
    B2268 Amiloride HCl dihydrate
    中文名: 盐酸阿米洛利二水合物
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Urokinases
    Summary: 有效上皮钠通道(ENaC)阻断剂
      ≥14.05 mg/mL
      insoluble in H2O
  4. Gallamine Triethiodide
    B1610 Gallamine Triethiodide
    中文名: 加拉碘铵,弛肌碘,戈拉碘铵
    Target: M2 Receptors
    Summary: 胆碱能受体阻断剂
      ≥44.58 mg/mL
      ≥54.6 mg/mL
  5. K02288
    B2286 K02288
    Target: ALK
    Summary: ALK抑制剂
      ≥17.6 mg/mL
      insoluble in H2O
  6. AZD-3463
    A8620 AZD-3463
     3 Citation
    Target: ALK|Insulin-like growth factors (IGFs)
    Summary: ALK/IGF1R抑制剂
      ≥11.22 mg/mL
      insoluble in H2O
  7. CH5424802
    A8393 CH5424802
    中文名: 阿来替尼
    Target: ALK
    Summary: ALK的有效ATP竞争性抑制剂
      ≥4.83 mg/mL
      insoluble in H2O
  8. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  9. Furosemide
    A8435 Furosemide
    中文名: 呋塞米
    Target: Na /K /Cl- Symporters (NKCCs)|GABAA Receptors
    Summary: GABAA受体拮抗剂
      ≥14.9 mg/mL
      insoluble in H2O
  10. Atropine sulfate monohydrate
    A8369 Atropine sulfate monohydrate
    中文名: 硫酸阿托品一水合物
    Target: M3 Receptors|M1 Receptors|M2 Receptors|M4 Receptors|M5 Receptors
    Summary: MAChRs拮抗剂
      ≥34.74 mg/mL
      ≥56.5 mg/mL

15件产品中的 1-10

页面
每页